Medite Cancer Diagnostics, Inc. (MDIT)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Jan 9, 2026
Medite Cancer Diagnostics Market Cap
Medite Cancer Diagnostics has a market cap or net worth of $8.58 thousand as of January 23, 2026. Its market cap has decreased by -99.82% in one year.
Market Cap
8.58K
Enterprise Value
n/a
Revenue
8.13M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since December 7, 1998, Medite Cancer Diagnostics's market cap has decreased from 591.70K to 8.58K, a decrease of -98.55%. That is a compound annual growth rate of -14.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 8.58K | -98.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lancer Orthodontics | 351.32K |
| Hear AtLast Holdings | 254.33K |
| InnerScope Hearing Technologies | 164.77K |
| American Scientific Resources | 16.68K |
| Remedent | 11.56K |
| Medical International Technology | 8.43K |
| BioLife Sciences | 4.83K |
| OJsys | 3.50K |